Background This report describes a nephelometric assay for measuring complement 3d (C3d).
Introduction
Estimation of complement activation is an important aid in the follow-up of patients with systemic rheumatic diseases such as systemic lupus erythematosus. 1 In these immunologically-mediated diseases, tissue damage is related to complement activation.
Activation of the complement system, either by the classical or by the alternative pathway, results in the degradation of complement 3 (C3). C3 is split by C3 convertases into C3a and C3b. C3b is further cleaved into C3c and C3d. C3d is metabolized slowly and is therefore a good indicator of complement activation. Because the various C3 fragments have di¡erent electrophoretic mobilities, C3d can be measured by a number of electrophoretic techniques, e.g. rocket electrophoresis. An alternative approach is to separate C3d from C3 and the other C3 degradation products by polyethylene glycol (PEG) precipitation. The molecular weight of the C3d fragment is about 35 kDa, whereas that of C3 is about 180 kDa. Because of this, these two molecules may be separated by polyethylene glycol precipitation. After separation, C3d can be measured either by radial immunodi¡usion 2 or by nephelometry. Although nephelometry is automated and allows the testing of a large number of samples, it is not widely used to measure C3d because of the weak signals obtained. Only a few authors have described nephelometric assays for the measurement of plasma C3d. 3, 4 In the present report, we describe and validate a new and simple nephelometric method for measuring C3d using an instrument that has recently become available, the Immage nephelometer (Beckman Coulter, Brea CA, USA). This instrument measures the change in rate of light scatter during the formation of antibody^antigen complexes at 5-s time intervals. The light source is a 670 nm laser and the detector is placed at a 908 angle to the incident laser beam. The reaction takes place in plastic cuvettes at 378C.
Methods

C3d assay by radial immunodiffusion
Radial immunodi¡usion (RID) was performed as described 2 using antibodies from the Central Laboratory of the Netherlands Red Cross Transfusion Service, Amsterdam, The Netherlands.
C3d assay by nephelometry
Venous blood was collected in EDTA tubes, centrifuged and the plasma stored at 7208C before assay. For production of a reference standard, serum from healthy adults was pooled and, after the addition of sodium azide, incubated at 378C for 7 days. This allowed the activation and breakdown of C3 into C3d. Five hundred microlitre aliquots were stored at 7708C.
This pooled serum was used to prepare a 100% C3d reference standard.
In order to separate C3d from native C3, 300 L of EDTA^plasma or pooled serum reference standard was mixed with 300 L of 22% (w/v) PEG 6000 in 50 mmol/ L borate, pH 8¢3. This mixture was then incubated for 3 h on ice, centrifuged at 1081 g for 30 min at 48C and the C3d-containing supernatant recovered. After PEG precipitation of the serum pool, C3d standard curves were prepared from dilutions of the C3d-containing supernatant. The 100% reference standard was ¢rst diluted 1 in 9 (v:v) in 11% (w/v) PEG 6000 (BDH Ltd, Poole, Dorset, England) in 50 mmol/ L borate bu¡er, pH 8¢3. This 11% reference standard was further diluted in 11% PEG 6000 in borate bu¡er 50 mmol/ L, pH 8¢3, to provide 8¢8%, 6¢6%, 4¢4%, 2¢2% and 1¢1% standards. Readings were taken in an Immage nephelometer (Beckman Coulter) in the user-de¢ned mode. To obtain the optimal reaction conditions, the concentrations of anti-C3d, bu¡er and PEG were all varied. The optimal assay system derived from these preliminary experiments involved a reaction containing 21 L of sample with 30 L of neat (polyclonal) anti-C3d (DAKO, Glostrup, Denmark) in 195 L of 5% (w/v) PEG 8000 (Sigma Chemical Co, St Louis MO, USA) in 20 mmol/ L borate, pH 8¢2. The instrument gain was set at four and the reaction time was 2 min.
Possible interference due to haemoglobin and lipid was studied. Specimens with no additional haemoglobin and with various added haemoglobin concentrations were prepared by a modi¢cation of the method of Glick et al. 5 Erythrocytes were lysed by adding distilled water. The samples were then stored at 7208C for 12 h before centrifugation. The in£uence of turbidity on the C3d assay was checked by adding a lipid emulsion (Intralipid 1 , Pharmacia & Upjohn, Uppsala, Sweden) to a pool of human plasma samples.
Immuno¢xation was performed with the Hydrasys 2 (Sebia, Issy-les-Moulineaux, France) automated electrophoresis system according to the manufacturer's instructions, using Hydragel 4 Bence Jones gels (Sebia). The polyclonal antibodies used were anti-C3 (Beckman Coulter) and anti-C3d (DAKO). The C3c reference material was purchased from Calbiochem Novabiochem, San Diego CA, USA.
Results and discussion
The Immage nephelometer uses a rate method for measurement of the signal generated by C3d precipitation. At the end of the reaction, the system mathematically calculates the rate of change of the scatter signal. From this rate of change the instrument response is calculated and used to compute the result.
For production of a reference standard, serum was pooled and incubated at 378C for 7 days. In order to verify that this prolonged incubation resulted in complete conversion of C3 to C3d, immuno¢xation with an anti-C3 and an anti-C3d antibody was performed on a fresh plasma sample, the reference pool postincubation and puri¢ed C3c. The results are shown in Fig. 1 . In the fresh plasma sample, immuno¢xation with the anti-C3 antibody revealed one main band, which represented native C3. The C3d antibody also reacted with C3d epitopes on native C3. Prolonged incubation of a serum pool resulted in the complete disappearance of the native C3 band. Immuno¢xation with the anti-C3d antiserum revealed a C3d band and immuno¢xation with anti-C3 antiserum revealed a band that migrated to the same position as puri¢ed C3c. Immuno¢xation of puri¢ed C3c with anti-C3 antiserum and anti-C3d antiserum showed that the anti-C3 antibody but not the anti-C3d antibody reacted with C3c. Taken together, these results demonstrate that prolonged incubation resulted in complete degradation of native C3 to C3d. These results also verify that the anti-C3 antibody does not cross-react with C3d and that the anti-C3d antibody does not crossreact with C3c.
In the next step, we tested the recovery of C3d and C3 from the PEG precipitation step. The reference pool was precipitated with various concentrations of PEG. The supernatant was diluted 1:20 in 50 mmol/ L borate bu¡er, pH 8¢3, and complement components were measured with nephelometry using the anti-C3 and anti-C3d antibody. Because the reference serum does not contain native C3, the anti-C3 antibody reacts mainly with C3c. The C3c concentration decreased signi¢cantly with increasing concentrations of PEG, whereas the C3d concentration decreased only slightly under those conditions. The C3c concentration amounted to 0¢65 g/L, 0¢61 g/L, 0¢08 g/L, 50 ¢06 g/ L and 50 ¢06 g/L in the supernatant of samples that had been respectively precipitated with 0%, 4%, 11%, 14%, and 16% PEG. Values for C3d were respectively 6 ¢ 9%, 6 ¢ 7%, 5 ¢ 15%, 4 ¢ 4% and 3 ¢ 7%. -C3 (lanes 1, 3 and 5) and an anti -C3d (lanes 2, 4 and 6) antibody on a fresh plasma sample (lanes 3 and 4) , the reference pool (lanes 5 and 6) and puri ed C3c (lanes 1 and 2) .
These data show that treatment with 11% PEG resulted in a reduction of the initial C3c and C3d concentrations to 13% and 74%, respectively. Figure 2 shows a typical pattern of light-scatter signal versus time for the C3d assay. The addition of the sample to the £ow cell results in a small decrease of light scatter. This signal rapidly stabilizes so that there is no rate signal at the time of addition of the antibody. This demonstrates the absence of non-speci¢c reactions when the sample is added and veri¢es that the signal appearing after the addition of the antibody really represents a speci¢c reaction with C3d. To study the possibility of non-speci¢c reactions attributable to a direct matrix e¡ect, the anti-C3d antiserum was replaced with bu¡er and then the rate signals were measured for ten samples with all other test conditions as described above. Nine of the samples gave results below the lowest point of the calibration curve (1¢1%) and one gave a value of 1¢1%.
Dilutions of the standard (see Methods section) were assayed and used for constructing a calibration curve. The calibration curve is displayed in Fig. 3 . A third-order polynomial regression analysis gave the best ¢t. Figure 2 displays the scatter-signal development versus instrument cycle for each of the standards.
The detection limit was evaluated by making a blank measurement (bu¡er as sample) in the presence of anti-C3d antiserum (nˆ10). Under these conditions, the C3d value was 51 ¢1% for nine samples and 1¢2% for one sample. Based on these data, the detection limit was estimated to be 2¢2%.
To verify that the assay was linear across the normal and pathological range, a sample containing a high C3d concentration (7¢2%) was diluted with increasing amounts (10%, 20%, 30%, 40%, 50%, 60%, 70%, 80% and 90%) of a sample with a low amount of C3d (1 ¢ 6%). Figure 4 shows the theoretical concentration versus the measured concentration. Linear regression analysis showed a correlation of r 2ˆ1 : yˆ0 ¢9735 (95% con¢dence region: 0¢932^1¢ 015) *x+0¢122 (95% con¢dence region: 70 ¢ 077 to 0¢321). All recoveries of C3d were better than 95%.
The within-run imprecision of the assay was determined by 20 repeated measurements of two human pools with di¡erent C3d concentrations (2¢3% and 7¢7%) in a single batch by the same operator. The intra-assay coe¤cient of variation (CV) was 3¢7% and 2¢5% for the pool with a mean C3d concentration of 2¢3% and 7¢7%, respectively. Between-run imprecision was determined from repeat measurements of a pool by several di¡erent operators. The pool was stored at 7208C and had a mean C3d concentration of 4 ¢ 5%. The inter-assay CV, calculated from 20 determinations on di¡erent occasions was 5¢6%. The inter-assay CV obtained using RID was 16% (mean C3d concentration was 1¢4%; nˆ23). Linearity of the complement 3d (C3d) assay. A sample containing a high C3d concentration (7¢2%) was diluted with increasing amounts (10%, 20%, 30%, 40%, 50%, 60%, 70%, 80% and 90%) of a sample containing a lower amount of C3d (1¢6%). C3d was assayed by nephelometry as described in Methods section. Figure 5 . Correlation between nephelometry and radial immunodiffusion. Presentation according to Bland and Altman. 6 C3dˆcomplement 3d.
The addition of haemoglobin up to a ¢nal concentration of 875 mg/ L to a human plasma pool with a C3d concentration of 3¢4% caused no signi¢cant change in the measured C3d result. To investigate the in£uence of turbidity on the C3d assay, a pool was supplemented with Intralipid to produce test samples, with ¢nal Intralipid concentrations ranging from 0 to 23¢4 g/L. Measurement of C3d in these samples showed no interference from turbidity.
The accuracy of the technique was evaluated by measuring C3d concentration in parallel in 93 samples by the nephelometric assay and by RID. Regression analysis (Passing and Bablok) of the results showed a correlation of rˆ0 ¢908: yˆ1 ¢231 (95% con-¢dence region: 1¢08^1¢438) *x+0¢375 (95% con¢dence region: 70 ¢066 to 0¢729). The presentation according to Bland and Altman 6 is presented in Fig. 5 and shows a bias of 70 ¢8%.
In conclusion, this new nephelometric assay for C3d is sensitive and speci¢c and is free from interference by turbidity and haemolysis. The technique is also precise and is much less time-consuming than RID.
